376 related articles for article (PubMed ID: 28668359)
1. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
Ahmadi Y; Ghorbanihaghjo A; Argani H
Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
[TBL] [Abstract][Full Text] [Related]
2. Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia.
Ermini L; Post M; Caniggia I
Curr Mol Pharmacol; 2017; 10(2):152-160. PubMed ID: 26758951
[TBL] [Abstract][Full Text] [Related]
3. Statins: perspectives in cancer therapeutics.
Corcos L; Le Jossic-Corcos C
Dig Liver Dis; 2013 Oct; 45(10):795-802. PubMed ID: 23490341
[TBL] [Abstract][Full Text] [Related]
4. Statins and protein prenylation in cancer cell biology and therapy.
Garcia-Ruiz C; Morales A; Fernandez-Checa JC
Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
[TBL] [Abstract][Full Text] [Related]
5. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
[TBL] [Abstract][Full Text] [Related]
6. [The anticancer properties of statins].
Sławińska A; Kandefer-Szerszeń M
Postepy Hig Med Dosw (Online); 2008 Aug; 62():393-404. PubMed ID: 18688209
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.
Sharon C; Baranwal S; Patel NJ; Rodriguez-Agudo D; Pandak WM; Majumdar AP; Krystal G; Patel BB
Oncotarget; 2015 Jun; 6(17):15332-47. PubMed ID: 25895029
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
Henneman L; van Cruchten AG; Kulik W; Waterham HR
Biochim Biophys Acta; 2011 Apr; 1811(4):227-33. PubMed ID: 21237288
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia.
Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G
J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922
[TBL] [Abstract][Full Text] [Related]
10. The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables.
Elson CE; Yu SG
J Nutr; 1994 May; 124(5):607-14. PubMed ID: 8169651
[TBL] [Abstract][Full Text] [Related]
11. The effects of statins with a high hepatoselectivity rank on the extra-hepatic tissues; New functions for statins.
Ahmadi Y; Mahmoudi N; Yousefi B; Karimian A
Pharmacol Res; 2020 Feb; 152():104621. PubMed ID: 31891788
[TBL] [Abstract][Full Text] [Related]
12. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells.
Göbel A; Thiele S; Browne AJ; Rauner M; Zinna VM; Hofbauer LC; Rachner TD
Cancer Lett; 2016 May; 375(1):162-171. PubMed ID: 26968247
[TBL] [Abstract][Full Text] [Related]
14. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
[TBL] [Abstract][Full Text] [Related]
15. Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer.
Elson CE; Peffley DM; Hentosh P; Mo H
Proc Soc Exp Biol Med; 1999 Sep; 221(4):294-311. PubMed ID: 10460692
[TBL] [Abstract][Full Text] [Related]
16. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
17. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
[TBL] [Abstract][Full Text] [Related]
18. Mevalonate-suppressive dietary isoprenoids for bone health.
Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
